✦ LIBER ✦

Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers

✍ Scribed by Kikutsuji, Toru ;Harada, Masamitsu ;Tashiro, Seiki ;Ii, Setsuko ;Moritani, Maki ;Yamaoka, Takashi ;Itakura, Mitsuo

Publisher: Springer
Year: 2000
Tongue: English
Weight: 178 KB
Volume: 7
Category: Article
ISSN: 0944-1166
DOI: 10.1007/s005340070021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of somatostatin receptor subt

Expression of somatostatin receptor subtypes in human brain tumors

✍ Anne Dutour; Ujendra Kumar; Rosemarie Panetta; L'Hovicine Ouafik; Federic Fina; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 261 KB 👁 2 views

Expression of mRNA for the 5 somatostatin receptors (sst 1-5 ) was characterized by Northern blot and RT-PCR analysis in 20 meningioma and 9 glioma samples. sst 1 mRNA was detectable by Northern blots of poly-A ؉ RNA in meningiomas but not gliomas. In contrast, sst 2 mRNA was readily detected by Nor

Attenuated ALK5 receptor expression in h

Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition

✍ Rae Lynn Baldwin; Helmut Friess; Munehiro Yokoyama; Martha E. Lopez; Michael S. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 724 KB

Transforming growth factor-6 (TGF-p) receptors constitute a family of transmembrane proteins that bind TGF-P ligands. In this study we assessed the growth responsiveness to TGF-P I in pancreatic cancer cell lines and characterized the levels of expression of TGF-f3 receptors in these cell lines and

Somatostatin receptor subtypes sst1, sst

Somatostatin receptor subtypes sst1, sst2, sst3 and sst5expression in human pituitary, gastroentero-pancreatic and mammary tumors

✍ Jean-Claude Schaer; Beatrice Waser; Guadalupe Mengod; Jean Claude Reubi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 692 KB

Using in situ hybridization techniques with selective oligoprobes, the gene expression of sst 1 , sst 2 , sst 3 and sst 5 was studied in a series of 32 human pituitary adenomas, 28 breast tumors and 21 endocrine gastroentero-pancreatic tumors, shown to express somatostatin receptors to variable exte

Somatostatin receptors in primary human

Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology

✍ U. Kumar; S. I. Grigorakis; H. L. Watt; R. Sasi; L. Snell; P. Watson; S. Chaudha 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 428 KB

Differential expression of epidermal gro

Differential expression of epidermal growth factor receptor in human head and neck cancers

✍ Li Dao Ke; Karen Adler-Storthz; Gary L. Clayman; Alfred W. K. Yung; Zhuo Chen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Background: Over-expression of human epidermal growth factor receptor (egfr) is associated with a variety of human malignancies, including head and neck cancer. it has also been studied for its effect on cancer cell responses to chemotherapy. to accurately measure changes in egfr expression that

Clinical utility of somatostatin recepto

Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: A case study and survey of somatostatin receptor subtype expression

✍ Robert C. Rostomily; Maria Elias; Mei Deng; Paul Elias; Donald E. Born; David Mu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

## Background: For tumors that express somatostatin receptors (sstr), radiolabeled somatostatin analogs, such as 111in-pentetreotide, can demonstrate the presence of tumor by radioligand uptake using somatostatin receptor scintigraphy (srs). the use of 111in-pentetreotide for srs depends on the spe